RPRX vs. YETI
RPRX (Royalty Pharma plc) and YETI (YETI Holdings, Inc.) are both stocks. RPRX operates in Biotechnology (Healthcare), while YETI operates in Leisure (Consumer Cyclical). Over the past 5 years, RPRX returned 6.56%/yr vs -11.89%/yr for YETI. At a 0.26 correlation, their price movements are largely independent.
Performance
RPRX vs. YETI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RPRX achieves a 43.38% return, which is significantly higher than YETI's 14.15% return.
RPRX
- 1D
- -0.76%
- 1M
- 3.50%
- YTD
- 43.38%
- 6M
- 44.31%
- 1Y
- 58.91%
- 3Y*
- 22.40%
- 5Y*
- 6.56%
- 10Y*
- —
YETI
- 1D
- -0.51%
- 1M
- 31.54%
- YTD
- 14.15%
- 6M
- 14.38%
- 1Y
- 60.32%
- 3Y*
- 11.13%
- 5Y*
- -11.89%
- 10Y*
- —
RPRX vs. YETI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
RPRX Royalty Pharma plc | 43.38% | 55.29% | -6.36% | -27.08% | 0.99% | -19.09% | 14.62% |
YETI YETI Holdings, Inc. | 14.15% | 14.70% | -25.63% | 25.34% | -50.13% | 20.97% | 90.88% |
Correlation
The correlation between RPRX and YETI is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2020 | 0.26 |
Fundamentals
RPRX:
$1.97
YETI:
$1.98
RPRX:
27.87
YETI:
25.42
RPRX:
0.03
YETI:
2.83
RPRX:
9.45
YETI:
2.12
RPRX:
$2.44B
YETI:
$1.90B
RPRX:
$1.81B
YETI:
$1.08B
RPRX:
$1.70B
YETI:
$245.40M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RPRX vs. YETI — Risk / Return Rank
RPRX
YETI
RPRX vs. YETI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Royalty Pharma plc (RPRX) and YETI Holdings, Inc. (YETI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RPRX | YETI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.29 | ||
| Sortino ratioReturn per unit of downside risk | +1.38 | ||
| Omega ratioGain probability vs. loss probability | 1.46 | 1.25 | +0.21 |
| Calmar ratioReturn relative to maximum drawdown | 8.02 | 2.02 | +6.00 |
| Martin ratioReturn relative to average drawdown | 20.12 | 4.43 | +15.69 |
Loading charts...
Drawdowns
RPRX vs. YETI - Drawdown Comparison
The maximum RPRX drawdown since its inception was -49.68%, smaller than the maximum YETI drawdown of -74.99%. Use the drawdown chart below to compare losses from any high point for RPRX and YETI.
Loading charts...
Drawdown Indicators
| RPRX | YETI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -49.68% | -74.99% | +25.31% |
Max Drawdown (1Y)Largest decline over 1 year | -7.38% | -30.08% | +22.70% |
Max Drawdown (3Y)Largest decline over 3 years | -21.14% | -49.74% | +28.60% |
Max Drawdown (5Y)Largest decline over 5 years | -41.98% | -74.99% | +33.01% |
Current DrawdownCurrent decline from peak | -1.79% | -53.20% | +51.41% |
Average DrawdownAverage peak-to-trough decline | -26.30% | -40.47% | +14.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.94% | 13.69% | -10.75% |
Volatility
RPRX vs. YETI - Volatility Comparison
The current volatility for Royalty Pharma plc (RPRX) is 6.38%, while YETI Holdings, Inc. (YETI) has a volatility of 12.35%. This indicates that RPRX experiences smaller price fluctuations and is considered to be less risky than YETI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RPRX | YETI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.38% | 12.35% | -5.97% |
Volatility (6M)Calculated over the trailing 6-month period | 13.96% | 28.74% | -14.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.00% | 42.24% | -20.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.82% | 48.50% | -24.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.85% | 53.18% | -26.33% |
Dividends
RPRX vs. YETI - Dividend Comparison
RPRX's dividend yield for the trailing twelve months is around 1.66%, while YETI has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
RPRX Royalty Pharma plc | 1.66% | 2.28% | 3.29% | 2.85% | 1.92% | 1.71% | 0.60% |
YETI YETI Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
RPRX vs. YETI - Financials Comparison
This section allows you to compare key financial metrics between Royalty Pharma plc and YETI Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RPRX vs. YETI - Profitability Comparison
RPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Royalty Pharma plc reported a gross profit of 0.00 and revenue of 631.00M. Therefore, the gross margin over that period was 0.0%.
YETI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, YETI Holdings, Inc. reported a gross profit of 210.21M and revenue of 380.41M. Therefore, the gross margin over that period was 55.3%.
RPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Royalty Pharma plc reported an operating income of 563.00M and revenue of 631.00M, resulting in an operating margin of 89.2%.
YETI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, YETI Holdings, Inc. reported an operating income of 12.44M and revenue of 380.41M, resulting in an operating margin of 3.3%.
RPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Royalty Pharma plc reported a net income of 295.00M and revenue of 631.00M, resulting in a net margin of 46.8%.
YETI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, YETI Holdings, Inc. reported a net income of 9.85M and revenue of 380.41M, resulting in a net margin of 2.6%.
Frequently Asked Questions
RPRX and YETI have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
YETI has higher volatility (12.35%) compared to RPRX (6.38%). In terms of maximum drawdown, RPRX dropped -49.68% vs YETI's -74.99%.
RPRX currently has the higher Sharpe Ratio (2.72 vs 1.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RPRX and YETI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer